Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
| Title: | Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin |
|---|---|
| Authors: | Capdevila, J.Aff1, Aff2, IDs41467023386115_cor1; Hernando, J.Aff1; Teule, A.Aff3; Lopez, C.Aff4; Garcia-Carbonero, R.Aff5; Benavent, M.Aff6; Custodio, A.Aff7; Garcia-Alvarez, A.Aff1; Cubillo, A.Aff8; Alonso, V.Aff9; Carmona-Bayonas, A.Aff10; Alonso-Gordoa, T.Aff11; Crespo, G.Aff12; Jimenez-Fonseca, P.Aff13; Blanco, M.Aff14; Viudez, A.Aff15; La Casta, A.Aff16; Sevilla, I.Aff17; Segura, A.Aff18; Llanos, M.Aff19; Landolfi, S.Aff20; Nuciforo, P.Aff21; Manzano, J. L.Aff22 |
| Source: | Nature Communications. 14(1) |
| Database: | Springer Nature Journals |